Portal de Periódicos da CAPES

Adjuvant adoptive immunotherapy against hepatocellular carcinoma

1998; Lippincott Williams & Wilkins; Volume: 28; Issue: 5 Linguagem: Inglês

10.1002/hep.510280539

1527-3350

Tadatoshi Takayama, Teruaki Sekine, Yasushi Kondo, Tadao Kakizoe, Masatoshi Makuuchi,

Immunotherapy and Immune Responses

HepatologyVolume 28, Issue 5 p. 1436-1437 CorrespondenceFree Access Adjuvant adoptive immunotherapy against hepatocellular carcinoma Tadatoshi Takayama M.D., Tadatoshi Takayama M.D. Departments of Surgery and Experimental Medicine, National Cancer Center, Tokyo, Japan; Second Department of Surgery, University of Tokyo, Tokyo, JapanSearch for more papers by this authorTeruaki Sekine Ph.D., Teruaki Sekine Ph.D. Departments of Surgery and Experimental Medicine, National Cancer Center, Tokyo, Japan; Second Department of Surgery, University of Tokyo, Tokyo, JapanSearch for more papers by this authorYasushi Kondo M.D., Yasushi Kondo M.D. Departments of Surgery and Experimental Medicine, National Cancer Center, Tokyo, Japan; Second Department of Surgery, University of Tokyo, Tokyo, JapanSearch for more papers by this authorTadao Kakizoe M.D., Tadao Kakizoe M.D. Departments of Surgery and Experimental Medicine, National Cancer Center, Tokyo, Japan; Second Department of Surgery, University of Tokyo, Tokyo, JapanSearch for more papers by this authorMasatoshi Makuuchi M.D., Masatoshi Makuuchi M.D. Departments of Surgery and Experimental Medicine, National Cancer Center, Tokyo, Japan; Second Department of Surgery, University of Tokyo, Tokyo, JapanSearch for more papers by this author Tadatoshi Takayama M.D., Tadatoshi Takayama M.D. Departments of Surgery and Experimental Medicine, National Cancer Center, Tokyo, Japan; Second Department of Surgery, University of Tokyo, Tokyo, JapanSearch for more papers by this authorTeruaki Sekine Ph.D., Teruaki Sekine Ph.D. Departments of Surgery and Experimental Medicine, National Cancer Center, Tokyo, Japan; Second Department of Surgery, University of Tokyo, Tokyo, JapanSearch for more papers by this authorYasushi Kondo M.D., Yasushi Kondo M.D. Departments of Surgery and Experimental Medicine, National Cancer Center, Tokyo, Japan; Second Department of Surgery, University of Tokyo, Tokyo, JapanSearch for more papers by this authorTadao Kakizoe M.D., Tadao Kakizoe M.D. Departments of Surgery and Experimental Medicine, National Cancer Center, Tokyo, Japan; Second Department of Surgery, University of Tokyo, Tokyo, JapanSearch for more papers by this authorMasatoshi Makuuchi M.D., Masatoshi Makuuchi M.D. Departments of Surgery and Experimental Medicine, National Cancer Center, Tokyo, Japan; Second Department of Surgery, University of Tokyo, Tokyo, JapanSearch for more papers by this author First published: 30 December 2003 https://doi.org/10.1002/hep.510280539Citations: 11AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat No abstract is available for this article. References 1 Bruix J. Treatment of hepatocellular carcinoma. Hepatology 1997; 25: 259–262.MEDLINE 2 Funaki NM, Tanaka J, Seto S, Kasamatsu T, Kaido T, Imamura M. Hematogenous spreading of hepatocellular carcinoma cells: possible participation in recurrence in the liver. Hepatology 1997; 25: 564–568.MEDLINE 3 Sekine T, Shiraiwa H, Yamazaki T, Tobisu K, Kakizoe T. A feasible method for expansion of peripheral blood lymphocytes by culture with immobilized anti-CD3 monoclonal antibody and interleukin-2 for use in adoptive immunotherapy of cancer patients. Biomed Pharmacother 1993; 47: 73–78.MEDLINE 4 Rosenberg SA, Lotze MT, Muul LM, Leitman S, Chang AE, Ettinghausen SE, Matory YL, et al. Observations on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer. N Engl J Med 1985; 313: 1485–1492.MEDLINE 5 Takayama T, Makuuchi M, Sekine T, Terui S, Shiraiwa H, Kosuge T, Yamazaki S, et al. Distribution and therapeutic effect of intraarterially transferred tumor-infiltrating lymphocytes in hepatic malignancies: a preliminary report. Cancer 1991; 68: 2391–2396.MEDLINE 6 Okuda K. Hepatocellular carcinoma: recent progress. Hepatology 1992; 15: 948–963.MEDLINE 7 Papadopoulos EB, Ladanyi M, Emanuel D, Mackinnon S, Boulad F, Carabasi MH, Castro-Malaspina H, et al. Infusions of donor leukocytes to treat Epstein-Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation. N Engl J Med 1994; 330: 1185–1191.MEDLINE Citing Literature Volume28, Issue5November 1998Pages 1436-1437 ReferencesRelatedInformation